Patent ID: 7749534

Claim:
A pharmaceutical agent consisting of: (1) cis-diammoniumdichloro-trans-dihydroxoplatinum(IV) (cis-oxoplatin) and/or salts thereof, and (2) a base material selected from a tablet, a capsule, and a coated tablet, wherein said base material and the cis-diammoniumdichloro-trans-dihydroxoplatinum(IV) are: a capsule consisting of cis-oxoplatin:silicon dioxide:mannitol or magnesium stearate at a ratio of 0.1 to 10:0.1 to 10:0.1 to 10; a tablet consisting of cis-oxoplatin:lactose:corn starch:poly(O-carboxymethyl)starch sodium salt:calcium hydrogen phosphate×2H 2 O:cellulose powder:magnesium stearate at a ratio of 10 to 500:20 to 150:1 to 10:1 to 10:1 to 10:1 to 10:0.1 to 7; and a tablet consisting of cis-oxoplatin silicon dioxide magnesium stearate at a ratio of 0.1 to 10:0.1 to 10:0.1 to 10.